Comprehensively Analyze the Prognosis Significance and Immune Implication of PTPRO in Lung Adenocarcinoma

Figure 2

Correlation between the expression level of PTPRO and clinical features in LUAD. (a) Heatmap of the clinical relevance of PTPRO expression level. (b–g) Differences in PTPRO expression level between different clinical subgroups (gender, age, TNM and stage).

(a)

(b)

(c)

(d)

(e)

(f)

(g)